High Dose Light Activated PRP Stem Cell Therapy

In 2001, following careers as Research Scientist and then Attorney, I came to Thailand and read in the Bangkok Post about how Thailand was offering stem cell therapies with adult stem cells. Stem cells were being harvested from a tube of patient’s blood, and after processing, were being re-injected with amazing results, particularly in the case of cardiac patients. Led by Thai cardiac physicians who had trained at Mt Sinai Hospital in New York, they were successfully treating American patients with severe heart disease.

Like those others of us that were overseas, it became clear to me that a lot of avant-garde research and treatment was going on around the world that was not happening in the USA. These advances were not even being reported in the US. There seemed to be a lot of opportunities to participate in this new field with more freedom from governmental regulation. Except for the USA where restrictions many times disable clinical progress, there was at that time the emergence of the new field of stem cell therapy- valuable and beneficial treatments using a patient’s own stem cells- that were being offered internationally, particularly in China, Thailand, Panama, and Russia.

I had hoped to establish a stem cell clinic in Thailand, but eventually, after a lot of development work, with initially welcoming attitude and offers of lab space, the Thais decided to keep this new field all to themselves and over time, that country became one of the world leaders in providing stem cell therapies using a patient’s own cells.

In 2017, forty-five years after the publication of my first research report as a young immunology scientist, and following years of study in the field of stem cell medicine, I was privileged to be included as co-author on the first definitive paper published in the US establishing the safety of adult stem cell therapy. The lead scientist for the paper was Dr. Kristin Comella, probably the most innovative clinical stem cell scientist in the US who has pioneered ways forward for adult stem cell treatment in the US via exceptions to the normal FDA rules, by classifying a patient treatment as either “patient specific clinical trial”, “treatment under Institutional Review Board Approval”, or “compassionate use”. The paper is “Safety Analysis of Autologous Stem Cell Therapy in a Variety of Degenerative Diseases and Injuries Using the Stromal Vascular Fraction”, J Clin Med Res 2017: 9(11): 935-942.

By 2023, I came to realize that Intravenous PRP therapy, where we take a few tablespoons of blood from a patient, concentrate and then activate the platelets before re-injection, is the best way to stimulate our own innate stem cells to effectuate repair and improvement of our most serious diseases and conditions. In June of that year, my colleague and I published a medical report titled “2023: High Dose Light Activated PRP the New Stem Cell Therapy” in which we detailed how to do the procedure for the first time. We in particular noted the requirement for light activation of platelets to release the growth factors and cytokines necessary to stimulate the body’s innate rejuvenation mechanisms.

In parallel, my private research company, Bengal Bioscience, developed a method to test saliva for the presence of the most important growth factors associated with stem cell therapies, thereby offering physicians and other clinicians a means to evaluate the various modalities being used.

My goal is to make this new therapy available to patients who might benefit, through my consultation and association with the patients’ health care providers. The procedure offers patients the highest level of stem cell therapy, yet only requires a blood draw similar to a blood test.

So, we can now demonstrate changes in growth factors and other molecules associated with any stem cell therapeutic and are not limited to looking at the improvement of a patient’s symptoms alone.

I am not a physician, and I do not give any medical advice. My activity is solely to assist health care providers in a complementary role by providing expertise in the procedure, and also by supplying the necessary processing equipment via my mobile service. Mobile PRP processing is available within the Wilmington, Hampstead, and Jacksonville, NC areas to any patient and their health care provider interested in trying the procedure. And as mentioned elsewhere, ALL PRP processing takes place in a sterile closed system.

My complete CV is here: Walter P Drake CV 2025